These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 10469746)

  • 21. Ovarian cancer and occupational exposure among pulp and paper employees in Norway.
    Langseth H; Kjaerheim K
    Scand J Work Environ Health; 2004 Oct; 30(5):356-61. PubMed ID: 15529799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis.
    Modugno F; Ness RB; Allen GO; Schildkraut JM; Davis FG; Goodman MT
    Am J Obstet Gynecol; 2004 Sep; 191(3):733-40. PubMed ID: 15467532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: revisiting old hypotheses.
    Fleming JS; Beaugié CR; Haviv I; Chenevix-Trench G; Tan OL
    Mol Cell Endocrinol; 2006 Mar; 247(1-2):4-21. PubMed ID: 16297528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between number of ovulatory cycles and accumulation of mutant p53 in epithelial ovarian cancer.
    Webb PM; Green A; Cummings MC; Purdie DM; Walsh MD; Chenevix-Trench G
    J Natl Cancer Inst; 1998 Nov; 90(22):1729-34. PubMed ID: 9827528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovulation and risk of epithelial ovarian cancer.
    Purdie DM; Bain CJ; Siskind V; Webb PM; Green AC
    Int J Cancer; 2003 Mar; 104(2):228-32. PubMed ID: 12569579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endometriosis and ovarian cancer: thoughts on shared pathophysiology.
    Ness RB
    Am J Obstet Gynecol; 2003 Jul; 189(1):280-94. PubMed ID: 12861175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Markers of inflammation and risk of ovarian cancer in Los Angeles County.
    Wu AH; Pearce CL; Tseng CC; Templeman C; Pike MC
    Int J Cancer; 2009 Mar; 124(6):1409-15. PubMed ID: 19065661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of high-grade serous ovarian cancer associated with pelvic inflammatory disease, parity and breast cancer.
    Stewart LM; Spilsbury K; Jordan S; Stewart C; Holman CDJ; Powell A; Reekie J; Cohen P
    Cancer Epidemiol; 2018 Aug; 55():110-116. PubMed ID: 29935395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced risk of ovarian cancer in women with a tubal ligation or hysterectomy. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives.
    Rosenblatt KA; Thomas DB
    Cancer Epidemiol Biomarkers Prev; 1996 Nov; 5(11):933-5. PubMed ID: 8922304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone.
    Risch HA
    J Natl Cancer Inst; 1998 Dec; 90(23):1774-86. PubMed ID: 9839517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New insights regarding pharmacologic approaches for ovarian cancer prevention.
    Rodriguez G
    Hematol Oncol Clin North Am; 2003 Aug; 17(4):1007-20, x. PubMed ID: 12959189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carcinogenic potential of ovulatory genotoxicity.
    Murdoch WJ
    Biol Reprod; 2005 Oct; 73(4):586-90. PubMed ID: 15958727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perineal use of talc and risk of ovarian cancer.
    Langseth H; Hankinson SE; Siemiatycki J; Weiderpass E
    J Epidemiol Community Health; 2008 Apr; 62(4):358-60. PubMed ID: 18339830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cosmetic talc and ovarian cancer.
    Longo DL; Young RC
    Lancet; 1979 Aug; 2(8138):349-51. PubMed ID: 89403
    [No Abstract]   [Full Text] [Related]  

  • 35. [Epidemiology of ovarian cancer].
    Tamaya T
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():435-40. PubMed ID: 15535283
    [No Abstract]   [Full Text] [Related]  

  • 36. Underlying mechanisms of ovarian cancer risk reduction after tubal ligation.
    Cibula D; Widschwendter M; Zikan M; Dusek L
    Acta Obstet Gynecol Scand; 2011 Jun; 90(6):559-63. PubMed ID: 21355863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perineal talc use and ovarian cancer: a critical review.
    Muscat JE; Huncharek MS
    Eur J Cancer Prev; 2008 Apr; 17(2):139-46. PubMed ID: 18287871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The 'incessant menstruation' hypothesis: a mechanistic ovarian cancer model with implications for prevention.
    Vercellini P; Crosignani P; Somigliana E; Viganò P; Buggio L; Bolis G; Fedele L
    Hum Reprod; 2011 Sep; 26(9):2262-73. PubMed ID: 21724568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prevention of breast cancer through reduced ovarian steroid exposure.
    Spicer DV; Pike MC
    Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Presence of talc in pelvic lymph nodes of a woman with ovarian cancer and long-term genital exposure to cosmetic talc.
    Cramer DW; Welch WR; Berkowitz RS; Godleski JJ
    Obstet Gynecol; 2007 Aug; 110(2 Pt 2):498-501. PubMed ID: 17666642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.